SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies -- Ignore unavailable to you. Want to Upgrade?


To: majaman1978 who wrote (112453)12/3/1999 12:36:00 PM
From: Mike McFarland  Read Replies (2) | Respond to of 119973
 
That looks like a pretty good pick
in this market where anything with
genomics attatched is awfully hot,
profitable?--unheard of! <g>

Nice find, Guess I will have to do
some queries on Google for Lark,
Genomics and Baylor.

My genomics pick today is GENXY, although
I don't have a trading positon...just another
one of those damn investments. Most of my
little biotechs are tiny...<100M marketcap...
but Genset seems rather underappreciated by
the market as well, could be a good play,
noted it on the MLNM thread this morning,
waiting for some feedback, a little thinly
traded tho.

Ah, here is something on Lark
Separately, as part of a decision to enhance the Company's long term asset potential, Lark is collaborating with Sennes Drug Innovations to develop senescence gene technology. This technology originated from Dr. Olivia Pereira-Smith's laboratory at Baylor. Lark is seeking to identify the genes involved in controlling cellular senescence. The Company believes these genes may have potential diagnostic and therapeutic applications, particularly in the field of cancer. Lark plans to identify corporate partners to maximize the commercial development of this technology as appropriate.
bcm.tmc.edu

Sounds like an interesting company.
informagen.com

Now that I've cluttered up this thread
...I see there is a thread here on SI too,
see you over there.
--MM